Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Messenger | 14 | 2025 | 1551 | 2.100 |
Why?
|
| RNA Precursors | 3 | 2024 | 76 | 1.470 |
Why?
|
| Sequence Analysis, RNA | 9 | 2024 | 180 | 1.420 |
Why?
|
| RNA Splicing | 4 | 2025 | 164 | 1.270 |
Why?
|
| Transcription Initiation Site | 3 | 2025 | 51 | 1.270 |
Why?
|
| Gene Expression Regulation | 13 | 2025 | 1621 | 1.260 |
Why?
|
| Transcription, Genetic | 8 | 2025 | 883 | 1.250 |
Why?
|
| Quantitative Trait Loci | 9 | 2017 | 77 | 1.100 |
Why?
|
| Alternative Splicing | 4 | 2022 | 130 | 1.000 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2025 | 3 | 0.950 |
Why?
|
| Transcription Termination, Genetic | 1 | 2025 | 3 | 0.950 |
Why?
|
| DNA Methylation | 5 | 2015 | 294 | 0.940 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 170 | 0.790 |
Why?
|
| Chromatin | 7 | 2025 | 616 | 0.780 |
Why?
|
| Introns | 4 | 2022 | 114 | 0.770 |
Why?
|
| Transcriptome | 2 | 2022 | 396 | 0.670 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2018 | 103 | 0.670 |
Why?
|
| RNA Polymerase II | 3 | 2025 | 87 | 0.660 |
Why?
|
| Islets of Langerhans | 1 | 2022 | 280 | 0.650 |
Why?
|
| Gene Expression | 3 | 2012 | 851 | 0.640 |
Why?
|
| Genetic Variation | 6 | 2017 | 387 | 0.630 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2014 | 102 | 0.520 |
Why?
|
| RNA Stability | 3 | 2022 | 103 | 0.510 |
Why?
|
| Genome, Human | 6 | 2015 | 240 | 0.480 |
Why?
|
| Pan troglodytes | 3 | 2014 | 32 | 0.480 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 706 | 0.450 |
Why?
|
| Exons | 5 | 2024 | 201 | 0.440 |
Why?
|
| Drosophila | 1 | 2017 | 439 | 0.430 |
Why?
|
| Models, Genetic | 2 | 2016 | 261 | 0.430 |
Why?
|
| Gene Expression Profiling | 9 | 2025 | 783 | 0.430 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 500 | 0.430 |
Why?
|
| Humans | 35 | 2025 | 64238 | 0.320 |
Why?
|
| Genome-Wide Association Study | 6 | 2015 | 361 | 0.310 |
Why?
|
| Polyadenylation | 3 | 2025 | 51 | 0.290 |
Why?
|
| Computational Biology | 3 | 2024 | 357 | 0.270 |
Why?
|
| RNA, Small Interfering | 3 | 2025 | 927 | 0.270 |
Why?
|
| Environment | 2 | 2018 | 123 | 0.270 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2024 | 313 | 0.250 |
Why?
|
| Models, Theoretical | 2 | 2018 | 272 | 0.250 |
Why?
|
| Animals | 11 | 2025 | 20961 | 0.250 |
Why?
|
| RNA Isoforms | 1 | 2025 | 6 | 0.240 |
Why?
|
| Caspase 8 | 1 | 2025 | 65 | 0.220 |
Why?
|
| Pyroptosis | 1 | 2025 | 34 | 0.220 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2025 | 81 | 0.210 |
Why?
|
| Transgenes | 1 | 2025 | 188 | 0.210 |
Why?
|
| Protein Isoforms | 2 | 2022 | 199 | 0.210 |
Why?
|
| Deoxyribonuclease I | 3 | 2012 | 41 | 0.210 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2022 | 145 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 5 | 2025 | 685 | 0.200 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2022 | 4 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2015 | 497 | 0.190 |
Why?
|
| Friedreich Ataxia | 1 | 2022 | 7 | 0.190 |
Why?
|
| Cell Line | 8 | 2017 | 2055 | 0.190 |
Why?
|
| Chromosome Mapping | 2 | 2015 | 290 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2025 | 329 | 0.190 |
Why?
|
| RNA Splice Sites | 3 | 2018 | 23 | 0.190 |
Why?
|
| Alleles | 3 | 2014 | 448 | 0.180 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 10 | 0.180 |
Why?
|
| Recombinational DNA Repair | 1 | 2021 | 25 | 0.180 |
Why?
|
| Tyrosinemias | 1 | 2021 | 20 | 0.180 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 443 | 0.170 |
Why?
|
| Cell Proliferation | 2 | 2022 | 1001 | 0.170 |
Why?
|
| Transcription Factors | 6 | 2017 | 1540 | 0.170 |
Why?
|
| DNA, Mitochondrial | 3 | 2011 | 87 | 0.170 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 172 | 0.170 |
Why?
|
| Inflammation | 2 | 2025 | 1162 | 0.170 |
Why?
|
| Base Sequence | 2 | 2022 | 1332 | 0.170 |
Why?
|
| Dendritic Cells | 2 | 2015 | 528 | 0.170 |
Why?
|
| Apoptosis | 1 | 2025 | 1094 | 0.160 |
Why?
|
| Huntingtin Protein | 1 | 2019 | 145 | 0.140 |
Why?
|
| Gene Ontology | 1 | 2018 | 38 | 0.140 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 34 | 0.140 |
Why?
|
| Mutation | 3 | 2019 | 2629 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2019 | 197 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 4 | 2012 | 416 | 0.130 |
Why?
|
| Gene Editing | 1 | 2021 | 324 | 0.130 |
Why?
|
| Huntington Disease | 1 | 2018 | 157 | 0.130 |
Why?
|
| Species Specificity | 2 | 2014 | 334 | 0.130 |
Why?
|
| Phosphorylation | 1 | 2018 | 948 | 0.120 |
Why?
|
| RNA Interference | 2 | 2025 | 618 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2021 | 889 | 0.110 |
Why?
|
| Dependovirus | 1 | 2021 | 721 | 0.110 |
Why?
|
| HapMap Project | 2 | 2012 | 5 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2015 | 153 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 1196 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1681 | 0.100 |
Why?
|
| Phenotype | 2 | 2015 | 1222 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 266 | 0.100 |
Why?
|
| Proteins | 1 | 2018 | 760 | 0.100 |
Why?
|
| RNA | 1 | 2016 | 429 | 0.100 |
Why?
|
| Pseudogenes | 1 | 2012 | 12 | 0.100 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 24 | 0.090 |
Why?
|
| Neurons | 1 | 2018 | 934 | 0.090 |
Why?
|
| Gene Dosage | 1 | 2012 | 65 | 0.090 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 38 | 0.090 |
Why?
|
| DNA Footprinting | 1 | 2012 | 18 | 0.090 |
Why?
|
| Tuberculosis | 2 | 2015 | 303 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2012 | 6 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 324 | 0.090 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2012 | 8 | 0.090 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 73 | 0.090 |
Why?
|
| Genetics, Population | 2 | 2009 | 44 | 0.090 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 391 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2025 | 167 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 103 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2015 | 416 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 727 | 0.090 |
Why?
|
| Nucleosomes | 1 | 2012 | 189 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 297 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2022 | 2176 | 0.080 |
Why?
|
| Population Dynamics | 1 | 2008 | 20 | 0.070 |
Why?
|
| Binding Sites | 1 | 2010 | 914 | 0.070 |
Why?
|
| DNA | 1 | 2012 | 844 | 0.070 |
Why?
|
| Neoplasms | 1 | 2018 | 1392 | 0.070 |
Why?
|
| Mice | 4 | 2025 | 11003 | 0.070 |
Why?
|
| Asthma | 1 | 2012 | 471 | 0.060 |
Why?
|
| Phylogeny | 1 | 2008 | 385 | 0.060 |
Why?
|
| Alagille Syndrome | 1 | 2006 | 2 | 0.060 |
Why?
|
| Receptor, Notch2 | 1 | 2006 | 8 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 214 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2012 | 697 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2025 | 3070 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2025 | 37 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2025 | 30 | 0.060 |
Why?
|
| Yersinia Infections | 1 | 2025 | 10 | 0.060 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 36 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2018 | 123 | 0.060 |
Why?
|
| Disease Resistance | 1 | 2025 | 24 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 77 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2025 | 260 | 0.050 |
Why?
|
| tau Proteins | 1 | 2025 | 204 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 122 | 0.050 |
Why?
|
| Cell Death | 1 | 2025 | 286 | 0.050 |
Why?
|
| Iron-Binding Proteins | 1 | 2022 | 11 | 0.050 |
Why?
|
| CCCTC-Binding Factor | 1 | 2022 | 39 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2014 | 66 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 149 | 0.050 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 62 | 0.040 |
Why?
|
| Software | 2 | 2018 | 388 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 466 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 396 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2140 | 0.040 |
Why?
|
| Genotype | 2 | 2012 | 668 | 0.040 |
Why?
|
| Macrophages | 1 | 2025 | 1053 | 0.040 |
Why?
|
| Haplotypes | 2 | 2009 | 134 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 32 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 28 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 3450 | 0.030 |
Why?
|
| Histones | 2 | 2011 | 486 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 540 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 302 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2015 | 21 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 405 | 0.030 |
Why?
|
| Cytosine | 1 | 2015 | 30 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 482 | 0.030 |
Why?
|
| Epigenomics | 1 | 2015 | 62 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 632 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 216 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2021 | 802 | 0.030 |
Why?
|
| Genes | 1 | 2014 | 90 | 0.030 |
Why?
|
| Female | 4 | 2021 | 33350 | 0.030 |
Why?
|
| Micrococcal Nuclease | 1 | 2012 | 13 | 0.020 |
Why?
|
| Male | 4 | 2021 | 30294 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 256 | 0.020 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2010 | 6 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 194 | 0.020 |
Why?
|
| DNA Cleavage | 1 | 2010 | 18 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 407 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 38 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 233 | 0.020 |
Why?
|
| Nigeria | 1 | 2010 | 9 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2010 | 30 | 0.020 |
Why?
|
| Gene Pool | 1 | 2009 | 1 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 5 | 0.020 |
Why?
|
| Senegal | 1 | 2009 | 17 | 0.020 |
Why?
|
| Philadelphia | 1 | 2009 | 24 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 146 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 165 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2009 | 130 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 123 | 0.020 |
Why?
|
| Russia | 1 | 2008 | 55 | 0.020 |
Why?
|
| Genome | 1 | 2010 | 276 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 263 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 607 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 979 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1618 | 0.020 |
Why?
|
| Pedigree | 1 | 2006 | 195 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 17116 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 17898 | 0.010 |
Why?
|